Page last updated: 2024-09-03

antiprimod and Myeloproliferative Disorders

antiprimod has been researched along with Myeloproliferative Disorders in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Burger, J; Creighton, CJ; Estrov, Z; Harris, D; Kantarjian, HM; Knez, L; Livun, A; Manshouri, T; Quintás-Cardama, A; Verstovsek, S; Zhang, Y	1

Other Studies

1 other study(ies) available for antiprimod and Myeloproliferative Disorders

Article	Year
Bone marrow stroma-secreted cytokines protect JAK2(V617F)-mutated cells from the effects of a JAK2 inhibitor. Cancer research, 2011, Jun-01, Volume: 71, Issue:11 Topics: Animals; Apoptosis; Bone Marrow Cells; Cell Growth Processes; Cell Line, Tumor; Cytokines; Drug Resistance; Humans; Interleukin-6; Janus Kinase 2; Mice; Mutation; Myeloproliferative Disorders; Signal Transduction; Spiro Compounds; Stromal Cells; Transfection	2011

Article

Year

Bone marrow stroma-secreted cytokines protect JAK2(V617F)-mutated cells from the effects of a JAK2 inhibitor.

Cancer research, 2011, Jun-01, Volume: 71, Issue:11

Topics: Animals; Apoptosis; Bone Marrow Cells; Cell Growth Processes; Cell Line, Tumor; Cytokines; Drug Resistance; Humans; Interleukin-6; Janus Kinase 2; Mice; Mutation; Myeloproliferative Disorders; Signal Transduction; Spiro Compounds; Stromal Cells; Transfection

2011